Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

A team led by Rensselaer Polytechnic Institute (RPI) professors Georges Belfort, Ph.D. (PI), and Pankaj Karande, Ph.D. (co-PI ...

A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...

As the immune system weakens with age, scientists have found a way to restore some of its lost strength. By delivering mRNA ...

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause ...

A UCLA-led research team has discovered a molecular switch that determines whether tiny blood vessels in premature infants' ...

RNA vaccines, such as those used against COVID-19, are effective at generating antibody responses. These antibodies are ...

Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental ...

Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the vital role MRNA technology played in COVID-19 vaccines.

MIT and Broad Institute researchers have developed an mRNA approach that temporarily programs liver cells to produce ...

A newly revealed molecular tug-of-war may have implications for better understanding how a multitude of diseases and ...

New data highlight liver-encoded delivery of immune modulators as a strategy to mitigate age-related immune dysfunction.